Psychopharmacology of conditioned reward: Evidence for a rewarding signal at D1-like dopamine receptors

Psychopharmacology

Volumn 144, Issue 2, 1999, Pages 95-110

  Sutton, Michael A ^a,b   Beninger, Richard J ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b YALE UNIVERSITY   (United States)

Author keywords

Conditioned reward; D1 receptor; Dopamine; Nucleus accumbens; Review

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 4,6,6A,7,8,12B HEXAHYDRO 7 METHYLINDOLO[4,3 AB]PHENANTHRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; APOMORPHINE; CHLORDIAZEPOXIDE; CHOLERA TOXIN; COCAINE; DOPAMINE 1 RECEPTOR; FENOLDOPAM; FLUPENTIXOL; METHYLPHENIDATE; NEUROTRANSMITTER; NEUROTROPIN; PIMOZIDE; PIPRADOL; QUINPIROLE;

ANIMAL EXPERIMENT; CONDITIONING; DOPAMINE BLOOD LEVEL; INFORMATION PROCESSING; LEARNING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; REWARD; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TRANSLATION REGULATION;

ANIMALS; CAUDATE NUCLEUS; CONDITIONING (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; NUCLEUS ACCUMBENS; REACTION TIME; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REWARD;

EID: 0032988583     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050982     Document Type: Review

References (129)

1. 1-like agonist SKF 82958 but not SKF 81297 or SKF 77434. Eur J Pharmacol 343:111-118
2. Bechara A, van der Kooy D (1989) The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned preferences produced by morphine and amphetamine. J Neurosci 9:3400-3409
3. Beitner-Johnson D, Nestler EJ (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57:344-347
4. Beitner-Johnson D, Nestler EJ (1993) Chronic morphine impairs mesolimbic transport in the rat mesolimbic dopamine system. NeuroReport 5:57-60
5. Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6:173-196
6. Beninger RJ (1989) Dissociating the effects of altered dopaminergic function on performance and learning. Brain Res Bull 23:365-371
7. Beninger RJ (1991) Receptor subtype-specific dopamine agonists and antagonists and conditioned behaviour. In: Willner P, Scheel-Krüger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, pp 273-299
8. 2 dopamine receptor interactions: neuroscience and neuropharmacology. Academic Press, London, pp 115-157
9. 1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev 22: 335-345
10. Beninger RJ, Phillips AG (1980) The effect of pimozide on the establishment of conditioned reinforcement. Psychopharmacology 68:147-153
11. Beninger RJ, Ranaldi R (1992) The effects of amphetamine, apomorphine, SKF 38393, quinpirole and bromocriptine on responding for conditioned reward in rats. Behav Pharmacol 3:155-163
12. Beninger RJ, Ranaldi R (1993) Microinjections of flupenthixol into the caudate-putamen but not the nucleus accumbens, amygdala or frontal cortex of rats produce intra-session declines in food-rewarded operant responding. Behav Brain Res 55: 203-212
13. Beninger RJ, Ranaldi R (1994) Dopaminergic agents with different mechanisms of action differentially affect responding for conditioned reward. In: Palomo T, Archer T (eds) Strategies for studying brain disorders: vol. 1. depressive, anxiety and drug abuse disorders. Farrand Press, London, pp 411-428
14. 1-like receptor agonists impair responding for conditioned reward in rats. Behav Pharmacol 6:1-9
15. Beninger RJ, Hanson DR, Phillips AG (1980) The effects of pipradrol on the acquisition of responding with conditioned reinforcement: a role for sensory preconditioning. Psychopharmacology 69:235-242
16. Beninger RJ, Hanson DR, Phillips AG (1981) The acquisition of responding with conditioned reinforcement: effects of cocaine, (+)-amphetamine and pipradrol. Br J Pharmacol 74:149-154
17. Beninger RJ, D'Amico CM, Ranaldi R (1993) Microinjections of flupenthixol into the caudate putamen of rats produce intrasession declines in food-rewarded operant responding. Pharmacol Biochem Behav 45:343-350
18. Bindra D (1974) A motivational view of learning, performance, and behaviour modification. Psychol Rev 81:199-213
19. Bolles RC (1972) Reinforcement, expectancy, and learning. Psychol Rev 79:394-409
20. Booth RG, Baldessarini RJ, Marsh E, Owens CE (1994) Actions of (+)-7-hydroxy-N-N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in linibic and extrapyramidal regions of rat brain. Brain Res 662:283-288
21. Bouyer JJ, Park DH, Joh TH, Pickel VM (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res 302:267-275
22. Braestrup C, Scheel-Krüger J (1976) Methylphenidate-like effects of the new anti-depressant drug, nomifensine (HOE 984). Eur J Pharmacol 38:305-312
23. Bugelski R (1938) Extinction with and without sub-goal reinforcement. J Comp Psychol 26:121-133
24. Burns LH, Robbins TW, Everitt, BJ (1993) Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine. Behav Brain Res 55:167-183
25. Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994) Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115:516-528
26. Cador M, Robbins TW, Everitt BJ (1989) Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience 30:77-86
27. Cador M, Taylor JR, Robbins TW (1991) Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology 104:377-385
28. Calabresi P, Pisani A, Mercuri NB, Bernardi G (1996) The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 19:19-24
29. Carr GD, White NM (1986) Anatomical dissociation of amphetamine's rewarding and aversive effects: an intracranial microdialysis study. Psychopharmacology 89:340-346
30. Cepeda C, Buchwald NA, Levine MS (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA 90:9576-9580
31. Chiodo LA, Berger TW (1986) Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum. Brain Res 375:198-203
32. Chu B, Kelley AE (1992) Potentiation of reward-related responding by psychostimulant infusion into nucleus accumbens: role of dopamine receptor subtypes. Psychobiology 20:153-162
33. Civelli O, Bunzow JR, Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 32: 281-307
34. Cohen SL (1991) Effects of d-amphetamine on responding under second-order schedules of reinforcement with paired and non-paired brief stimuli. J Exp Anal Behav 56:289-302
35. Cohen SL, Branch MN (1991) Food-paired stimuli as conditioned reinforcers: effects of d-amphetamine. J Exp Anal Behav 56:277-288
36. Colpaert FC, van Bever WFM, Leyson JEMP (1976) Apomorphine: chemistry, pharmacology, biochemistry. Int Rev Neurobiol 19:225-268
37. Crawley JN (1992) Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. J Neurosci 12:3380-3393
38. Cunningham ST, Kelley AE (1992a) Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward. Brain Res 588:104-114
39. Cunningham ST, Kelley AE (1992b) Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward. Brain Res Bull 29:675-680
40. Fletcher PJ (1995) Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine. Psychopharmacology 118:155-163
41. Fletcher PJ (1996) Injection of 5-HT into the nucleus accumbens reduces the effects of d-amphetamine on responding for conditioned reward. Psychopharmacology 126:62-69
42. Fletcher PJ, Higgins GA (1997) Differential effects of ondansetron and α-flupenthixol on responding for conditioned reward. Psychopharmacology 134:64-72
43. 1B receptors in the nucleus accumbens attenuates the potentiating effect of amphetamine on responding for conditioned reward. Soc Neurosci Abstr 23:832.4
44. Fletcher PJ, Sabijan MS, De Sousa NJ (1996) Effects of d-amphetamine injected into the nucleus accumbens or ventral pallidum on locomotion and responding for a conditioned reward. Soc Neurosci Abstr 22:69.9
45. Fletcher, PJ, Korth, KM, Sabijan, MS, DeSousa NJ (1998) Injections of d-amphetamine into the ventral pallidum increase locomotor activity and responding for conditioned reward: a comparison with injections into the nucleus accumbens. Brain Res 805:29-40
46. Flores-Hernández J, Galarraga E, Bargas J (1997) Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse 25: 185-195
47. Freund TF, Powell JF, Smith AD (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13:1189-1215
48. 2+ conductance. J Neurosci 17:3334-3342
49. Hill RT (1970) Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In: Costa E, Garattini S (eds) Amphetamine and related compounds. Raven Press, New York, pp 781-785
50. Hoffman DC, Beninger RJ (1985) The effects of pimozide on the establishment of conditioned reinforcement as a function of the amount of conditioning. Psychopharmacology 87:454-460
51. 2 agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning. Pharmacol Biochem Behav 31:1-8
52. Hökfelt T, Rehfeld JF, Skirboll L, Ivemark B, Goldstein M, Markey K (1980) Evidence for co-existence of dopamine and CCK in meso-limbic neurones. Nature 285:476-478
53. Horger BA, Iyasere CA, Nestler EJ, Taylor JR (1997) Chronic intra-accumbens BDNF infusions enhance responding for conditioned reward after I.P. cocaine and induce locomotor sensitization. Soc Neurosci Abstr 23:433.2
54. Inglis WL, Dunbar JS, Winn P (1994) Outflow from the nucleus accumbens to the pedunculopontine tegmental nucleus: a dissociation between locomotor activity and the acquisition of responding for conditioned reinforcement stimulated by d-amphetamine. Neuroscience 62:51-64
55. Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 257:850-860
56. Jones GH, Marsden CA, Robbins TW (1990) Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens. Psychopharmacology 102:364-372
57. B receptors with amphetamine in responding for conditioned rewards. Peptides 16:959-964
58. A receptor antagonist. Pharmacol Biochem Behav 55: 439-444
59. B receptor antagonist, microinjected into the nucleus accumbens and the expression of conditioned rewarded behavior. Neurosci Lett 209:85-88
60. A receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity. Psychopharmacology 123:131-143
61. Kelleher RT (1966) Chaining and conditioned reinforcement. In: Honig WK (ed) Operant behavior: areas of research and application. Appleton Century Crofts, New York, pp 160-212
62. Kelley AE, Delfs JM (1991a) Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions. Psychopharmacology 103:187-196.
63. Kelley AE, Delfs JM (1991b) Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area. Psychopharmacology 103: 197-203
64. Kelley AE, Holahan MR (1997) Enhanced reward-related responding following cholera toxin infusion into the nucleus accumbens. Synapse 26:46-54
65. Kelley AE, Throne LC (1992) NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res Bull 29:247-254
66. Kelley AE, Smith-Roe SL, Holahan MR (1997) Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proc Natl Acad Sci USA 94:12174-12179
67. Killcross AS, Everitt BJ, Robbins TW (1997) Symmetrical effects of amphetamine and alpha-flupenthixol on conditioned punishment and conditioned reinforcement: contrasts with midazolam. Psychopharmacology 129:141-152
68. Kiyatkin EA (1995) Functional significance of mesolimbic dopamine. Neurosci Biobehav Rev 19:573-598
69. Knott PD, Clayton KN (1966) Durable secondary reinforcement using brain stimulation as the primary reinforcer. J Comp Physiol Psychol 61:151-153
70. 3H]raclopride. Brain Res 532:342-346
71. Konradi C. Leveque J-C, Hyman SE (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 16:4231-4239
72. Koob GF, Simon H, Herman JP, Le Moal M (1984) Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems. Br Res 303:319-329
73. 1a-deficient mutant mice. J Neurosci 15:5870-5882
74. Mackintosh NJ (1974) The psychology of animal learning. Academic Press, London
75. 3H]-2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol Pharmacol 36: 518-524
76. 1 agonist. In: Sandler M, Dahlström A, Belmaker RH (eds) Progress in catecholamine research part B: central aspects. Liss, New York, pp 59-64
77. Mazurski EJ, Beninger RJ (1986) The effects of (+)-amphetamine and apomorphine on responding for a conditioned reinforcer. Psychopharmacology 90:239-243
78. McGeorge AJ, Faull RLM (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29:503-537
79. 1 receptor as a primary site of therapeutic action of neuroleptic drugs. Prog Neurobiol 34:143-183
80. Moore KE, Chiueh CC, Zeldes G (1977) Release of neurotransmitters from the brain in vivo by amphetamine, methylphenidate and cocaine. In: Ellinwood EN Jr, Kilbey MM (eds) Cocaine and other stimulants. Plenum Press, New York, pp 143-160
81. 1 dopamine receptor: behavioural and neurochemical comparasin of CY 208-243 with SKandF 101384 and SKandF 103243. Pharmacol Biochem Behav 35:105-110
82. Neisewander JL, Ong A, MacGonigle P (1995) Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ. Synapse 19: 134-143
83. Neve KA, Neve RL (1997) Molecular biology of dopamine receptors. In: Neve KA, Neve RL (eds) The dopamine receptors. Humana Press, Totowa, NJ, pp 781-785
84. Nielson IM, Pederson V, Nymark M, Franck KF, Boeck V, Fjalland B, Christensen AV (1973) The comparative pharmacology of flupenthixol and some reference neuroleptics. Acta Pharmacol Toxicol 33:353-362
85. Niznik HB, Van Tol HHM (1992) Dopamine receptor genes: new tools for molecular psychiatry. J Psychiatr Neurosci 17:158-180
86. 1 receptor. Neuropharmacology 28:401-104
87. Olmstead MC, Franklin KBJ (1994) Lesions of the pedunculopontine tegmental nucleus block drug-induced reinforcement but not amphetamine-induced locomotion. Brain Res 638:29-35
88. Olmstead MC, Robbins TW, Everitt BJ (1997) The role of the NBM in conditioned and unconditioned responses to appetitive stimuli. J Psychopharmacol II:A90
89. Ostrowski NL, Hatfield CB, Caggiula AR (1982) The effects of low doses of morphine on the activity of dopamine-containing cells and on behaviour. Life Sci 31:2347-2350
90. Parkinson JA, Olmstead MC, Burns LH, Robbins TW, Everitt BJ (1997) Dissociation in effects of lesions in the nucleus accumbens core and shell in appetitive Pavlovian approach behaviour and the potentiation of conditioned reinforcement and locomotor activity by d-amphetamine. J Neurosci 19:2401-2411
91. Phelix CF, Broderick PA (1995) Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens. Brain Res Bull 37:37-40
92. Phillips GD, Le Noury J, Wolterink G, Donselaar-Wolterink I, Robbins TW, Everitt BJ (1993) Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement. Behav Brain Res 55:223-231
93. Phillips GD, Robbins TW, Everitt BJ (1994) Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer. Psychopharmacology 114:345-359
94. 2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats. Psychopharmacology 113:110-118
95. 1 receptor function. Psychopharmacology 118:437-443
96. Ranaldi R, Roberts DCS (1996) Initiation, maintenance and extinction of cocaine self-administration with and without conditioned reward. Psychopharmacology 128:89-96
97. 1 agonist SKF 38393 attenuates amphetamine-produced responding for conditioned reward in rats. Pharmacol Biochem Behav 52:131-137
98. Robbins TW (1975) The potentiation of conditioned reinforcement by psychomotor stimulant drugs: a test of Hill's hypothesis. Psychopharmacologia 45:103-114
99. Robbins TW (1976) Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs. Nature 264:57-59
100. Robbins TW (1978) The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine. Psychopharmacology 58:79-87
101. Robbins TW, Everitt BJ (1982) Functional studies of the central catecholamines. Int Rev Neurobiol 23:303-365
102. Robbins TW, Koob GF (1978) Pipradrol enhances reinforcing properties of stimuli paired with brain stimulation. Pharmacol Biochem Behav 8:219-222
103. Robbins TW, Watson BA, Gaskin M, Ennis C (1983) Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacology 80:113-119
104. 2 receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience 64:1019-1034
105. Robledo P, Robbins TW, Everitt BJ (1996) Effects of excitotoxic lesions of the central amygdaloid nucleus on the potentiation of reward-related stimuli by intra-accumbens amphetamine. Behav Neurosci 110:981-990
106. Salamone JD (1994) The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res 61:117-133
107. Scheel-Krüger J (1971) Comparative studies of various amphetamine analogues demonstrating different interaction with the metabolism of the catecholamines in the brain. Eur J Pharmacol 14:47-59
108. Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593-1599
109. Self DW, Nestler EJ (1995) Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495
110. 2, receptors. Psychopharmacology 123:303-306
111. Setler PE, Sarau HM, Zircle CL, Saunders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419-430
112. 2 dopamine receptor interactions: neuroscience and pharmacology. Academic Press, London, pp 1-17
113. Skinner BF (1938) The behavior of organisms. Appleton Century Crofts, New York
114. Stein L (1958) Secondary reinforcement established with subcortical stimulation. Science 127:466-467
115. Studler JM, Reibaud M, Herve D, Blanc G, Tassin JP (1986) Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens. Eur J Pharmacol 126:125-128
116. Taylor JR, Horger BA (1999) Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization. Psychopharmacology 142:31-40
117. Taylor JR, Robbins TW (1984) Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology 84:405-412
118. Taylor JR, Robbins TW (1986) 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology 90: 390-397
119. Tjon GHK, De Vries TJ, Ronken E, Hogenboom F, Wardeh G et al (1994) Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its δ-and κ-opioid regulation. Eur J Pharmacol 252:205-212
120. Vaccarino FJ (1994) Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci Biobehav Rev 18:207-214
121. Westerink BHC (1979) The effects of drugs on dopamine biosynthesis and metabolism in the brain. In: Horn AS, Korf J, Westerink BHC (eds) The neurobiology of dopamine. Academic Press, London, pp 255-291
122. Westerink BHC (1995) Brain microdialysis and its application for the study of animal behaviour. Behav Brain Res 70:103-124
123. Westley JK, Ormerod B, Beninger RJ (1998) Inhibition of protein kinase A in the nucleus accumbens impairs amphetamine-produced enhancement of responding for conditioned reward. Soc Neurosci Abstr 24:175
124. Whitelaw RB, Markou A, Robbins TW, Everitt BJ (1996) Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology 127:213-224
125. Wickens J (1990) Striatal dopamine in motor activation and reward-mediated learning: steps toward a unifying model. J Neural Transm 80:9-31
126. Wickens J, Kötter R (1995) Cellular models of reinforcement. In: Houle JC, Davis JL, Beiser DG (eds) Models of information processing in the basal ganglia. MIT, Boston, pp 187-214
127. Wickens JR, Begg AJ, Arbuthnott GW (1996) Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro. Neuroscience 70:1-6
128. 2 dopamine receptors in responding with conditioned reinforcement. Psychopharmacology 110:355-364
129. 1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. J Pharmacol Exp Ther 271:1462-1470